MCE
Matrix Composites & Engineering Limited
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ฐ Dividends
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual capital growth
๐ฐ
6.67%
Annual dividend yield
Based on the most recent dividend
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Matrix Composites & Engineering Ltd. engages in the design, engineering, and manufacture of composite and material technology solutions for the oil and gas, civil and infrastructure, resources, defense, and transportation industries. The company is headquartered in Perth, Western Australia. The company went IPO on 2009-11-16. Its principal activities include the manufacture and supply of capital drilling equipment (primarily comprised of syntactic foam buoyancy) and provision of inspection, maintenance and repair services to the oil and gas sector; manufacture and supply of subsea umbilical risers and flowline (SURF) ancillary equipment and associated services; manufacture and supply of VIV suppression equipment for rigid pipelines; manufacture and supply of well construction products, including centralizers and conductors; distribution of epoxy based coating system and related equipment hire and technical support; and consultancy for, and manufacture of, advanced composite materials and products for the defense, energy, resource and transport sectors.
๐ Performance
Price History
-88.64%
1M
10Y
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ฐ Dividends
Payouts
๐ฐ Annual Dividend Yield*
6.67%
๐ฐ Annual Dividend Earnings Per $1,000 invested**
$66.67
๐ฐ Most Recent Dividend Franked Percentage Estimate
100.00%
๐ฐ Average Dividend Franked Percentage Estimate
100.00 %
๐ฐ Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.33
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in MCE
1
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in MCE
821 days
MCE investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
100%
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
100%
๐ Legal gender of investors
Female
100%
Male
Pearlers who invest in MCE also invest in...
ETPMPM.AX was created on 2009-01-02 by Global X. The fund's investment portfolio concentrates primarily on broad market commodities. ETFS Physical Precious Metals Basket (ETPMPM.AX) is designed to offer investors a simple, cost-efficient and secure way to access physical gold, silver, platinum and palladium by providing a return equivalent to the movements in the spot price of the metals less the applicable management fee.
๐ Share price
$207.30 AUD
NULL GLOBAL
NULL SMART BETA
NULL THEMATIC
NULL RESOURCES
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,000 full-time employees. The Companyโs areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Companyโs segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Companyโs CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Companyโs geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSLโs products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.
๐ Share price
$308.11 AUD
NULL HEALTH
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an Australasian animal care brand owner, product marketer, and distributor. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, such as own brands, retail healthcare, medical devices, capital equipment, pharmacy services, and wholesale activities. The Animal Care segment incorporates the sale of animal care products in a range of sectors, own brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid, TerryWhite Chemmart, and Pharmacy Wholesalers Russells, among others. Its Contract Logistics business includes Healthcare Logistics and Healthcare Logistics Clinical Trials. Its Institutional Healthcare includes Clinect, Cryomed Aesthetics and Onelink, among others.
๐ Share price
$39.25 AUD
Kalium Lakes Ltd. is an exploration and development company, which engages in the exploration and evaluation of mineral resources. The company is headquartered in Balcatta, Western Australia. The company went IPO on 2016-12-22. The firm is engaged in the exploration and mining of mineral resources in Australia. The company is focused on the development of its Beyondie Sulphate of Potash (SOP) Project (BSOPP) in Western Australia. The Beyondie SOP Project comprises about 16 granted exploration licenses, two mining leases, and several miscellaneous licenses covering an area of approximately 1,800 square kilometers. This sub-surface brine deposit supplies an evaporation and processing operation located approximately 160 kilometers (km) southeast of Newman. The company has tenement interests in Dora / Blanche Prospect. The company also has tenement interests in Carnegie Potash Project (Joint Venture). The Carnegie Joint Venture (CJV) is located approximately 220 km east-north-east of Wiluna. The CJV's exploration licenses include E38/2995, E38/2973, E38/2928, E38/3297, E38/5296 and E38/3295, which covers a total area of about 3,040 square kilometers.
๐ Share price
$0.02 AUD
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
๐ Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...